It's a synergistic blend of three distinct peptides, each with a unique role, working in concert like a world-class orchestra
Safety Considerations and UK Regulatory Status Retatrutide is not MHRA-approved, meaning self-use outside clinical trials carries risks including product impurity, incorrect dosing, gastrointestinal adverse effects, and no pharmacovigilance oversight
The goal of this study was to compare the efficacy and safety of NASO B12 with oral methylcobalamin tablets in treating the deficiency of vitamin B12 in patients receiving metformin for the management of diabetes
Discontinue use and consult a healthcare provider if you experience: Severe allergic reactions (rash, difficulty breathing, swelling), persistent injection site infections, or any concerning symptoms that do not resolve
Four sprays daily provide 720mcg of sublingual B12